Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- The History of AstraZeneca's Mismarketing of Seroquel
- AstraZeneca knew as far back as 2000 that Seroquel, its atypical antipsychotic, could cause diabetes in users. Since then, 15,000 consumers have sued the company. Documents describing AZ's early knowledge of Seroquel's risks surfaced in court, according to Bloomberg. In one document, AZ Global Safety Officer Wayne Geller concluded there...
- Blog posts 2008-12-05
- FDA Asks AZ to Tighten Seroquel Label; 9,000 Lawsuits Start Trials Next Week
- UPDATE: An early victory for AstraZeneca. A Florida judge just dismissed the first two cases on motions for summary judgment. So, er ... never mind! Next week in Orlando federal court the first of 9,000 lawsuits filed against AstraZeneca's antipsychotic Seroquel will was to go to trail....
- Blog posts 2009-01-28
- Seroquel Trial: Allegations of Sex-for-Secrets; AZ Wants Papers Sealed
- AstraZeneca is to argue in a Florida court next month that documents turned up in a lawsuit over weight-gain side effects of Seroquel should remain secret and sealed. The company is arguing it would be better for public health for Seroquel patients not to read the papers, according to The...
- Blog posts 2009-02-17
- Exec Warned AZ on Negative Seroquel Results: "We Cannot Hide Them"; Info Later "Buried"
- AstraZeneca should promote publications manager John Tumas (if he's still with the company) and give him a bonus. In the ongoing Seroquel trials in Florida, he alone is emerging as the voice of reason inside that company. Back story: AstraZeneca is accused of marketing its antipsychotic without...
- Blog posts 2009-02-27
- E-Mail: AstraZeneca Knew in 1997 that Seroquel Caused Weight Gain
- AstraZeneca knew as far back as 1997 that Seroquel put patients at risk of weight gain, according to the company's own internal memos. The documents also appear to show that some AZ execs developed strategies to "neutralize" information that suggested Seroquel caused weight gain or diabetes, even after the FDA...
- Blog posts 2009-03-03
- AstraZeneca's "Smoke and Mirrors" Man Has New Job in Medical Writing
- Whatever happened to AstraZeneca's "smoke and mirrors" man, Richard Lawrence? You remember him. He was the one who, in 1997, wrote a memo about Seroquel that praised the company's efforts to put a "positive spin" on "this cursed study," and added: I am not 100% comfortable with this data...
- Blog posts 2009-04-06
Additional Resources
- AstraZeneca's Sex-for-Studies Seroquel Scandal: Did Research Chief Bias the Science?
- An AstraZeneca executive in charge of clinical research on Seroquel had sexual affairs with a researcher and a study writer, plaintiffs in a Florida lawsuit claim. BNET first wrote about the sex-for-secrets aspect of the Seroquel litigation on Feb. 17. Now Furious Seasons blogger Philip Dawdy revealed...
- Blog posts 2009-02-25
- AstraZeneca's Seroquel Research Director Confessed to Sex-for-Studies Affairs
- Former AstraZeneca U.S. medical director for Seroquel Wayne MacFadden confessed his multiple sexual affairs, and his offer of drugs to one of the women he was sleeping with, to lawyers in December 2007. The confessions include descriptions of sex in hotel rooms paid for by AZ, illicit...
- Blog posts 2009-03-12
- AZ outlined 'weight-neutral' Seroquel pitch
- More internal documents have surfaced in AstraZeneca's Seroquel fight, Bloomberg reports. The latest: A "dear colleague" letter from marketing official Debbie Holdsworth, stating that AstraZeneca's "global strategy is to demonstrate to consumers that Seroquel has a weight-neutral profile." That letter was dated 2001, plaintiff's attorney Ed Blizzard pointed out, four...
- News items 2009-10-08
- AZ Seroquel Trial: Was It "Ghostwriting" or "Professional" Writing?
- The lawsuits filed against AstraZeneca over whether the company failed to warn Seroquel users of the weight gain and diabetes risks associated with the drug throws up an interesting sidelight on the practice of "ghostwriting." Back in 2005, according to the British Medical Journal and the Guardian,...
- Blog posts 2009-03-20
- Judge: Send federal Seroquel suits to courts
- While AstraZeneca preps for its first Seroquel liability trials at the state level, federal lawsuits are coming closer to court as well. U.S. District Judge Anne Conway, who's overseeing pretrial work for thousands of federal Seroquel cases, said she will ask a panel of judges to send all those cases...
- News items 2009-11-19
- NAMI Board Member Was Paid Consultant on AZ's Seroquel, Documents Say
- Jim Dailey, a former National Alliance of the Mentally Ill policy director and board member, was a paid consultant for AstraZeneca's Seroquel marketing team, according to a set of documents that include a contract Dailey signed with the company. Download the NAMI/Seroquel documents here. ...
- Blog posts 2009-10-22
- AstraZeneca to Pay $520 Million to Settle Four Seroquel Cases - NYT
- The pharmaceutical company AstraZeneca said Thursday that it had reached a $520 million agreement to settle two federal investigations and two whistle-blower lawsuits over the sale and marketing of its blockbuster psychiatric drug Seroquel. One of the investigations related to "selected...
- News items 2009-10-30
- FDA Clears Zeneca's SEROQUEL for the Management of the Manifestations of Psychotic Disorders, Including Schizophrenia - r - quetiapine fumarate
- WILMINGTON, Del.--BUSINESS WIRE--September 29, 1997--Zeneca Pharmaceuticals today announced that the Food and Drug Administration FDA has cleared for marketing SEROQUELr quetiapine fumarate tablets, an oral medication indicated for the management of the manifestations of psychotic disorders, including schizophrenia. SEROQUEL is a new "atypical" antipsychotic agent in a new chemical...
- Research articles 1997-09-29
- FDA warns of Seroquel, Serzone errors
- The FDA has warned healthcare professionals about prescribing errors involving AstraZeneca's Seroquel quetiapine fumarate and Bristol-Myers Squibb's Serzone nefazodone hydrochloride. The medication errors resulted from a similarity in names, overlapping strengths (100 mg and 200 mg), dosage form tablets, the dosing interval BID, as well as the fact that both...
- Research articles 2002-08-01
- AstraZeneca Q1: Seroquel Sales Up; Faces 10,000 Lawsuits; Company Thinks It Will Beat the Rap
- AstraZeneca is facing nearly 10,000 lawsuits over claims that the company failed to warn people that its antipyschotic, Seroquel, could give patients diabetes. The update came on news that Seroquel sales actually went up in Q1 2009, rising to $1.1 billion from $1 billion. by Jim Edwards
- Blog posts 2009-05-01
- AZ Seroquel Emails Detail Off-Label Promotion; What Did CEO Brennan Know?
- A new batch of email and memos from the federal litigation over AstraZeneca's antipsychotic Seroquel detail company executives discussing off-label promotion, the stretching of data to make claims that Seroquel did not cause weight gain, the cover-up of a trial that showed negative results and suggestions that researchers who "slow...
- Blog posts 2009-05-20
- AstraZeneca Seems to Be Winning the War Against Seroquel
- AstraZeneca seems to be winning its war against the 10,000 plaintiffs who claim Seroquel causes weight gain and diabetes. A judge ruled that there was not enough evidence that Seroquel triggered a woman's diabetes because she was already unhealthy by the time she started taking the drug. by Jim Edwards
- Blog posts 2009-06-11
- AZ Call Notes Expose Secret Life of Seroquel Reps ... And It's Mostly Scandal-Free
- The release of AstraZeneca's sales rep call notes in the Seroquel litigation is mostly good news for the company. Bloomberg highlighted some grim anecdotes in its coverage -- one rep told a doctor that Seroquel did not cause diabetes and another offered doctors $1,500 "grants" -- but the majority of...
- Blog posts 2009-09-23
- FDA: Seroquel sales aid is misleading
- THE FDA HAS asked AstraZeneca to halt distribution of a professional sales aid used to market its antipsychotic medication Seroquel.
- Research articles 2007-01-01
- << Previous
- page 1 of 1
- Next >>
